See more : Garanti Faktoring A.S. (GARFA.IS) Income Statement Analysis – Financial Results
Complete financial analysis of Sharps Technology, Inc. (STSSW) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Sharps Technology, Inc., a leading company in the Financial – Capital Markets industry within the Financial Services sector.
- Ladam Affordable Housing Limited (LAHL.BO) Income Statement Analysis – Financial Results
- Taiga Motors Corporation (TAIG.TO) Income Statement Analysis – Financial Results
- Guizhou Salvage Pharmaceutical Co.,Ltd. (600227.SS) Income Statement Analysis – Financial Results
- China Bohai Bank Co., Ltd. (9668.HK) Income Statement Analysis – Financial Results
- TRxADE HEALTH, Inc. (MEDS) Income Statement Analysis – Financial Results
Sharps Technology, Inc. (STSSW)
Industry: Financial - Capital Markets
Sector: Financial Services
Website: https://sharpstechnology.com
About Sharps Technology, Inc.
Sharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in Melville, New York.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 891.25K | 654.57K | 28.70K | 11.04K | 10.59K |
| Gross Profit | -891.25K | -654.57K | -28.70K | -11.04K | -10.59K |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 1.61M | 2.28M | 1.69M | 827.01K | 388.02K |
| General & Administrative | 8.52M | 6.46M | 2.81M | 1.51M | 1.51M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 1.66M |
| SG&A | 8.52M | 6.46M | 2.81M | 1.51M | 1.66M |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 10.13M | 8.74M | 4.50M | 2.33M | 2.05M |
| Cost & Expenses | 10.13M | 8.74M | 4.50M | 2.33M | 2.06M |
| Interest Income | 0.00 | 1.32K | 769.00 | 3.33K | 3.60K |
| Interest Expense | 138.12K | 1.32M | 167.52K | 0.00 | 0.00 |
| Depreciation & Amortization | 891.25K | 654.57K | 28.70K | 11.04K | 10.59K |
| EBITDA | -8.98M | -2.66M | -4.47M | -2.33M | -2.04M |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -10.13M | -8.74M | -4.50M | -2.33M | -2.06M |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 255.01K | 4.10M | -166.75K | -6.87K | 3.59K |
| Income Before Tax | -9.87M | -4.64M | -4.66M | -2.34M | -2.06M |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | -30.00K | -5.42M | 166.75K | 6.87K | 3.00 |
| Net Income | -9.84M | 779.89K | -4.83M | -2.35M | -2.06M |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.76 | 0.10 | -0.53 | -0.26 | -0.22 |
| EPS Diluted | -0.76 | 0.10 | -0.53 | -0.26 | -0.22 |
| Weighted Avg Shares Out | 13.03M | 8.10M | 9.17M | 9.17M | 9.17M |
| Weighted Avg Shares Out (Dil) | 13.03M | 8.10M | 9.17M | 9.17M | 9.17M |
Source: https://incomestatements.info
Category: Stock Reports